While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening guidelines and reinforces the importance of proactive health monitoring, regardless of one’s fitness level.
Article links:
With new research published every week and the endless stream of nutrition information and opinions…
A major new study led by Wayne Batchelor, MD, an interventional cardiologist and President of…
Spring 2026 Safety Grade is a national recognition for commitment to patient safety Fairfax, VA…
When you walk into Letta’s treatment room on infusion day, a small disco ball throws…
Fairfax, VA – Inova Schar Cancer has been approved for a funding award from the…
Not all mental health struggles look the same. Inova offers a full range of behavioral…